$2.38
0.041.71%
Last update: Sep 2, 1:16 PM
Aptevo Therapeutics Inc (APVO) Stock Price, Quote, News & History
APVONASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aptevo Therapeutics (APVO) stock?
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Who are Aptevo Therapeutics (APVO) competitors?
Other companies in Aptevo Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Aptevo Therapeutics (APVO) stock?
Aptevo Therapeutics has a consensus price target of $8.00.
What is the current price for Aptevo Therapeutics (APVO)?
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $2.38 last updated September 2, 2026 at 1:16 PM EDT.
Does Aptevo Therapeutics (APVO) pay a dividend?
There are no upcoming dividends for Aptevo Therapeutics.
When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?
Aptevo Therapeutics does not have any upcoming earnings scheduled.
Is Aptevo Therapeutics (APVO) going to split?
There is no upcoming split for Aptevo Therapeutics.
What sector and industry does Aptevo Therapeutics (APVO) operate in?
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
